Fig 1.
Adult patients with positive sputum or bronchoalveolar lavage fluid for pulmonary melioidosis were identified (n = 36) after excluding those younger than 18 years of age and those with colonization of Burkholderia pseudomallei.
Table 1.
Baseline characteristics.
Fig 2.
Severity of ARDS in pulmonary melioidosis patients.
The dark blue bar represented the number of survival patients and the yellow bar represented the number of dead patients in a group of acute respiratory distress syndrome (ARDS). Comparing severities of ARDS (mild, moderate and severe) with chi-square test reported p = 0.04. Abbreviation: ARDS, acute respiratory distress syndrome.
Fig 3.
Clinical course of pulmonary melioidosis.
Pulmonary melioidosis with respiratory clinical course of non-acute respiratory distress syndrome (ARDS) and ARDS patients at 0-12 and 12-24 hours after admission. The total number of patients with non-ARDS = 13 patients and with ARDS = 23 patients.
Table 2.
Respiratory and laboratory parameters.
Table 3.
Microbiologic findings and pulmonary melioidosis treatment.
Table 4.
Factors associated with ARDS development in pulmonary melioidosis patients.